News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
34,044 Results
Type
Article (1030)
Company Profile (1)
Press Release (33013)
Section
Business (14785)
Career Advice (93)
Deals (1858)
Drug Development (3558)
Employer Resources (1)
FDA (553)
Job Trends (815)
News (19852)
Policy (851)
Tag
Academia (32)
Accelerated approval (1)
Allergies (7)
Alliances (1268)
ALS (4)
Alzheimer's disease (50)
Antibody-drug conjugate (ADC) (22)
Approvals (601)
Artificial intelligence (8)
Autoimmune disease (13)
Automation (1)
Bankruptcy (8)
Best Places to Work (742)
Biosimilars (4)
Bladder cancer (6)
Brain cancer (1)
Breast cancer (65)
Cancer (268)
Cardiovascular disease (27)
Career advice (78)
CAR-T (13)
Cell therapy (24)
Cervical cancer (2)
Clinical research (3158)
Collaboration (24)
Compensation (17)
Complete response letters (1)
COVID-19 (71)
CRISPR (1)
C-suite (5)
Cystic fibrosis (5)
Data (434)
Depression (5)
Diabetes (34)
Diagnostics (329)
Digital health (2)
Drug discovery (4)
Drug pricing (1)
Duchenne muscular dystrophy (10)
Earnings (13630)
Editorial (1)
Employer resources (2)
Events (6035)
Executive appointments (3)
FDA (809)
Fibrodysplasia Ossificans Progressiva (2)
Frontotemporal dementia (2)
Funding (19)
Gene editing (6)
Generative AI (1)
Gene therapy (23)
GLP-1 (37)
Government (88)
Grass and pollen (1)
Guidances (145)
Healthcare (855)
Huntington's disease (1)
IgA nephropathy (6)
Immunology and inflammation (7)
Immuno-oncology (2)
Indications (6)
Infectious disease (77)
Inflammatory bowel disease (14)
Influenza (1)
Intellectual property (20)
Interviews (19)
IPO (1411)
Job creations (116)
Job search strategy (62)
JPM (1)
Kidney cancer (1)
Labor market (2)
Layoffs (8)
Legal (124)
Liver cancer (5)
Lung cancer (31)
Lymphoma (31)
Machine learning (1)
Manufacturing (7)
MASH (12)
Medical device (774)
Medtech (778)
Mergers & acquisitions (459)
Metabolic disorders (59)
Multiple sclerosis (5)
Neurodegenerative disease (10)
Neuropsychiatric disorders (6)
Neuroscience (87)
NextGen: Class of 2026 (215)
Non-profit (96)
Obesity (14)
Opinion (2)
Ovarian cancer (6)
Pain (4)
Pancreatic cancer (5)
Parkinson's disease (7)
Patents (46)
Patient recruitment (15)
Peanut (4)
People (993)
Phase 1 (936)
Phase 2 (1269)
Phase 3 (1175)
Pipeline (630)
Postmarket research (149)
Preclinical (473)
Prostate cancer (8)
Radiopharmaceuticals (16)
Rare diseases (29)
Real estate (129)
Recruiting (2)
Regulatory (788)
Reports (1)
Research institute (62)
Resumes & cover letters (17)
RSV (3)
Schizophrenia (7)
Series A (4)
Series B (5)
Sickle cell disease (9)
Startups (63)
Tariffs (1)
The Weekly (1)
Vaccines (14)
Venture capital (1)
Weight loss (6)
Women's health (6)
Date
Today (2)
Last 7 days (38)
Last 30 days (102)
Last 365 days (1928)
2026 (130)
2025 (1942)
2024 (2278)
2023 (2602)
2022 (3013)
2021 (3011)
2020 (2634)
2019 (2078)
2018 (1364)
2017 (1144)
2016 (719)
2015 (1169)
2014 (745)
2013 (537)
2012 (603)
2011 (568)
2010 (5676)
Location
Africa (32)
Alabama (1)
Arizona (11)
Asia (1855)
Australia (228)
California (753)
Canada (206)
China (54)
Colorado (36)
Connecticut (28)
Delaware (35)
Europe (4910)
Florida (91)
Georgia (20)
Hawaii (1)
Idaho (2)
Illinois (69)
India (2)
Indiana (40)
Japan (28)
Kansas (3)
Kentucky (2)
Louisiana (7)
Maine (14)
Maryland (81)
Massachusetts (465)
Michigan (17)
Minnesota (62)
Missouri (3)
Montana (1)
Nevada (8)
New Hampshire (5)
New Jersey (208)
New York (169)
North Carolina (90)
Northern California (408)
Ohio (20)
Pennsylvania (136)
Puerto Rico (1)
South America (57)
Southern California (291)
Tennessee (6)
Texas (75)
United States (2493)
Utah (28)
Virginia (7)
Washington State (57)
Wisconsin (6)
34,044 Results for "123".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Five Leading Cancer Centers Unite to Target CD123 and Eradicate Hidden Leukemia Cells
December 12, 2025
·
4 min read
Press Releases
Orum Therapeutics Presents Preclinical Data at ASH 2025 Demonstrating Potent and Selective Antitumor Activity of ORM-1153, a CD123-Targeting Degrader Antibody Conjugate for Acute Myeloid Leukemia
December 9, 2025
·
4 min read
Press Releases
Myelofibrosis Treatment Market Outlook: Projected to Exceed USD 2.75 Billion by 2032 with a 12.3% CAGR
October 1, 2025
·
1 min read
Obesity
Pfizer’s First Weight-Loss Data After Metsera Buy ‘Look Competitive’
With data from a mid-stage trial showing weight loss of up to 12.3% at 28 weeks in patients treated with PF’3944, “Pfizer is moving full speed into obesity clinical development,” BMO Capital Markets said Tuesday.
February 3, 2026
·
2 min read
·
Tristan Manalac
Press Releases
TORL BioTherapeutics Secures $96M Series C Financing and Presents Updated Phase 1 Results of Novel Claudin 6 Targeted Antibody-Drug Conjugate TORL-1-23 at the 2025 European Society of Medical Oncology Congress
October 8, 2025
·
5 min read
Press Releases
ADA 2025 | Laekna Presented Clinical and Pre-clinical Studies Results of LAE102, LAE103 and LAE123
June 23, 2025
·
8 min read
Press Releases
Asahi Kasei Pharma Starts Phase III Study of Promising CIPN Prevention Therapy, ART-123 (Recomodulin™), to Enhance Treatment Options Worldwide
July 3, 2025
·
3 min read
Press Releases
CARB-X Grants Debiopharm an Additional $12.3 Million to Advance Development of Novel Antibiotic Against Gonorrhea
May 28, 2025
·
5 min read
Press Releases
Innate Pharma Regains Its Rights on CD123 Targeting ANKET® and Announces Sanofi’s Intention to Make a Strategic Investment in the Company
April 23, 2025
·
7 min read
Cell-Free RNA Isolation and Extraction Kits Market Reach USD123.94 Million by 2031
Global Cell-Free RNA Isolation & Extraction Kits Market is valued at US$ 41.55 Mn in 2023, and it is expected to reach US$ 123.94 Mn by 2031, with a CAGR of 14.90% during the forecast period of 2024-2031.
April 17, 2024
·
4 min read
1 of 3,405
Next
